Burzynski Research InstituteBZYR +36.75% Return-on-Tangible-Equity is 0.00% as of Nov. 2025. Among 1,195 Biotechnology companies, Burzynski Research Institute ranks worse than 83681.92% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Burzynski Research Institute's annualized net income for the quarter that ended in Nov. 2025 was $-1.32 Mil. Burzynski Research Institute's average shareholder tangible equity for the quarter that ended in Nov. 2025 was $-0.07 Mil. Therefore, Burzynski Research Institute's annualized Return-on-Tangible-Equity for the quarter that ended in Nov. 2025 was N/A%.
The historical rank and industry rank for Burzynski Research Institute's Return-on-Tangible-Equity or its related term are showing as below:
BZYR's Return-on-Tangible-Equity is not ranked *
in the Biotechnology industry.
Industry Median: -42.21 * Ranked among companies with meaningful Return-on-Tangible-Equity only.
Burzynski Research Institute (OTCPK:BZYR) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Burzynski Research Institute Return-on-Tangible-Equity Related Terms
Burzynski Research Institute Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Burzynski Research Institute Return-on-Tangible-Equity Chart
BZYR vs AGTX, EMMA, ATXI: Return-on-Tangible-Equity Comparison
For the Biotechnology subindustry, Burzynski Research Institute's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burzynski Research Institute Return-on-Tangible-Equity vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Burzynski Research Institute's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Burzynski Research Institute's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Nov. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Burzynski Research Institute (BZYR) has a Return-on-Tangible-Equity of 0.00% as of Nov. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Burzynski Research Institute and its competitors. According to the industry distribution chart, Burzynski Research Institute ranks #999999 out of 1195 companies in the Biotechnology industry.
Is Burzynski Research Institute's Return-on-Tangible-Equity too high?
Burzynski Research Institute's current Return-on-Tangible-Equity is 0.00%. Based on the distribution chart, Burzynski Research Institute ranks #999999 out of 1195 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does Burzynski Research Institute's Return-on-Tangible-Equity compare to AGTX and EMMA?
According to the Biotechnology industry distribution chart, Burzynski Research Institute ranks #999999 out of 1195 companies for Return-on-Tangible-Equity. This places Burzynski Research Institute in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Biotechnology company?
A good Return-on-Tangible-Equity depends on the Biotechnology industry context. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Burzynski Research Institute and its competitors. Burzynski Research Institute's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burzynski Research Institute stock overvalued right now?
Burzynski Research Institute (BZYR) has a current Return-on-Tangible-Equity of 0.00%. The current Return-on-Tangible-Equity is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Burzynski Research Institute (BZYR), the current Return-on-Tangible-Equity is 0.00% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Burzynski Research Institute Inc operates as a research and development facility of Antineoplaston drugs currently being tested for the use in the treatment of cancer, and provides consulting services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BZYR has been successfully added to your 